<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02667652</url>
  </required_header>
  <id_info>
    <org_study_id>776117</org_study_id>
    <nct_id>NCT02667652</nct_id>
  </id_info>
  <brief_title>The Curative Effect of the Length of the Jejunum Exclusion in Grstric Bypass Surgery for Type 2 Diabetes</brief_title>
  <official_title>The Curative Effect of the Length of the Jejunum Exclusion in Grstric Bypass Surgery for Type 2 Diabetes:a Randomized Controlled Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weidong Tong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Third Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the curative effect of the length of the jejunum
      exclusion in gastric surgry for T2DM and metabolic syndrome,and to draft Scientific and
      reasonable operation parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, there is a growing evidence supports the efficacy of Roux-en-Y gastric bypass for
      the treatment of Type 2 diabetes mellitus. However,there still have a great controversy about
      the operation parameters. With randomized controlled trial, Patients of BMI&gt;21kg/m2 with type
      2 diabetes were randomly divided into two groups: short biliarypancreatic limb:50cm;long
      biliarypancreatic limb :100cm. The investigators followed-up 3,6,12,24 months of the change
      of BMI,FBG,HbA1c,Blood pressure,Blood fat after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body mass idex</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>IFG</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood fat</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>short biliarypancreatic limb</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>short biliarypancreatic limb</description>
  </arm_group>
  <arm_group>
    <arm_group_label>long biliarypancreatic limb</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>long biliarypancreatic limb</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>short biliarypancreatic limb</intervention_name>
    <description>biliarypancreatic limb:50cm;roux limb:150cm.</description>
    <arm_group_label>short biliarypancreatic limb</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>long biliarypancreatic limb</intervention_name>
    <description>biliarypancreatic limb:100cm;roux limb:100cm.</description>
    <arm_group_label>long biliarypancreatic limb</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 20-65 years old

          -  History of diabetes is less than 15 years

          -  Fasting c-peptide≥1.6

          -  BMI≥21kg/m2；

          -  Ability to understand the nature of the procedure and willing to follow postoperative
             routine lifestyle and checkups

        Exclusion Criteria:

          -  Psychological and mental disorders

          -  Serious important organs such as heart and lung disease cannot be tolerated surgery

          -  Complex history of abdominal surgery in the abdominal cavity adhesion

          -  Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tong Weidong, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Daping Hospital, Third Military Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Daping hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Shi Z. Prevalence of diabetes among men and women in China. N Engl J Med. 2010 Jun 24;362(25):2425; author reply 2426. doi: 10.1056/NEJMc1004671.</citation>
    <PMID>20573933</PMID>
  </reference>
  <reference>
    <citation>Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012 Apr 26;366(17):1577-85. doi: 10.1056/NEJMoa1200111. Epub 2012 Mar 26.</citation>
    <PMID>22449317</PMID>
  </reference>
  <reference>
    <citation>Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 Apr 26;366(17):1567-76. doi: 10.1056/NEJMoa1200225. Epub 2012 Mar 26.</citation>
    <PMID>22449319</PMID>
  </reference>
  <reference>
    <citation>Gleysteen JJ. Five-year outcome with gastric bypass: Roux limb length makes a difference. Surg Obes Relat Dis. 2009 Mar-Apr;5(2):242-7; discussion 247-9. doi: 10.1016/j.soard.2008.08.005. Epub 2008 Aug 19.</citation>
    <PMID>18996751</PMID>
  </reference>
  <reference>
    <citation>Huang CK, Lee YC, Hung CM, Chen YS, Tai CM. Laparoscopic Roux-en-Y gastric bypass for morbidly obese Chinese patients: learning curve, advocacy and complications. Obes Surg. 2008 Jul;18(7):776-81. doi: 10.1007/s11695-007-9373-y. Epub 2008 May 16.</citation>
    <PMID>18483835</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2016</study_first_submitted>
  <study_first_submitted_qc>January 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2016</study_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Third Military Medical University</investigator_affiliation>
    <investigator_full_name>Weidong Tong</investigator_full_name>
    <investigator_title>Gastric &amp; Colorectal Division, General Surgery Dept. Daping Hospital</investigator_title>
  </responsible_party>
  <keyword>T2DM</keyword>
  <keyword>RYGB</keyword>
  <keyword>RCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Ethics Committee of Daping Hospital</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

